These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7128134)
1. Metabolism of injectable formulations of contraceptive steroids in obese and thin women. Fotherby K; Koetsawang S Contraception; 1982 Jul; 26(1):51-8. PubMed ID: 7128134 [TBL] [Abstract][Full Text] [Related]
2. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate. Fotherby K; Saxena BN; Shrimanker K; Hingorani V; Takker D; Diczfalusy E; Landgren BM Fertil Steril; 1980 Aug; 34(2):131-9. PubMed ID: 7409232 [TBL] [Abstract][Full Text] [Related]
3. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683 [TBL] [Abstract][Full Text] [Related]
4. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh. Swenson I; Khan AR; Jahan FA Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of different doses of Depo Provera. Fotherby K; Koetsawang S; Mathrubutham M Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera. Mora G; Johansson ED Contraception; 1976 Sep; 14(3):343-50. PubMed ID: 824097 [TBL] [Abstract][Full Text] [Related]
7. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women. Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353 [TBL] [Abstract][Full Text] [Related]
8. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Jeppsson S; Gershagen S; Johansson ED; Rannevik G Acta Endocrinol (Copenh); 1982 Mar; 99(3):339-43. PubMed ID: 6461995 [TBL] [Abstract][Full Text] [Related]
10. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418 [TBL] [Abstract][Full Text] [Related]
12. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics. Rahimy MH; Cromie MA; Hopkins NK; Tong DM Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of sustained release systems. Fotherby K J Steroid Biochem; 1979 Jul; 11(1B):457-9. PubMed ID: 491616 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters. Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019 [TBL] [Abstract][Full Text] [Related]
15. Transfer of contraceptive steroids in milk of women using long-acting gestagens. Koetsawang S; Nukulkarn P; Fotherby K; Shrimanker K; Mangalam M; Towobola K Contraception; 1982 Apr; 25(4):321-31. PubMed ID: 6213373 [TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration. Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624 [TBL] [Abstract][Full Text] [Related]
17. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users. Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367 [TBL] [Abstract][Full Text] [Related]
18. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone. Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279 [TBL] [Abstract][Full Text] [Related]
19. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives. Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206 [TBL] [Abstract][Full Text] [Related]
20. Some metabolic and hormonal changes in women using long acting injectable contraceptives. Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]